Earnings History Data for Satellos Bioscience Inc. (MSCLF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Satellos Bioscience Inc.
Satellos Bioscience Inc. is a regenerative medicine company dedicated to developing novel therapeutics which stimulate or restore muscle regeneration in severe disorders. The company's lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy. Satellos Bioscience Inc., formerly known as iCo Therapeutics Inc., is based in Toronto, Ontario.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13-11-2024 | PM | MSCLF | Satellos Bioscience Inc. | 72.00 | -0.06 | -0.05 | 0.00 | Satellos Bioscience Inc. GAAP EPS of -C$0.08 misses by $0.04 [11/13/2024 11:31 AM] |
0.62 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.23 - 0.67 | 118,459 | 0 | 0 | ||
28-08-2023 | PM | MSCLF | Satellos Bioscience Inc. | 13.00 | -0.04 | -0.03 | 0.00 | Satellos Bioscience reports Q2 results [8/29/2023 9:44 AM] |
0.3258 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.03 - 0.67 | 5,000 | 0 | 0 | ||
30-05-2023 | PM | MSCLF | Satellos Bioscience Inc. | 17.00 | -0.03 | -0.04 | 0.00 | Satellos Bioscience GAAP EPS of -C$0.04 in-line [5/31/2023 5:32 AM] |
0.46 | 0.05 (12.20%) |
0.0 | 0.0 (0.00%) |
0.03 - 1.00 | 2,500 | 0 | 0 | ||
23-11-2022 | PM | MSCLF | Satellos Bioscience Inc. | 5.00 | -0.04 | -0.05 | 0.00 | Satellos Bioscience GAAP EPS of -$0.05 [11/24/2022 3:09 AM] |
0.1164 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 1.14 | 200 | 0 | 0 | ||